SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Development GitHubs Reliability Woes Threaten Microsofts AI Coding Leadership Amid Rising Competition SK Hynix Posts Record Profit on AIDriven Chip Demand Beating Expectations Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience Philip Carrets Investment Philosophy Sound Balance Sheets Minimal Debt and Responsible Management Key to LongTerm Value Healthcare and Tech Rally Push SP 500 to Modest Gain XCF Global Inc SAFX Q1 2026 Earnings Small EPS Surprise Fuels Stock Rally Amid Revenue Uncertainty CLVT Q1 2026 Earnings EPS Beat Lifts Sentiment but Revenue Uncertainty and Stock Decline Raise Caution FN Q1 2026 Earnings EPS Beats Estimates Surprise of 147 Hilltop Holdings Inc Q1 2026 Earnings EPS Beat Surprises Analysts by 30 SENEA Q1 2026 Earnings Strong EPS of 619 Drives Stock Rally SVCO Q1 2026 Earnings EPS Surprises to the Upside Despite Narrower Loss Stock Rises Krispy Kreme Holds Steady at 337 as Support and Resistance Levels Come into Focus Associated BancCorp ASB Faces Headwinds as Shares Dip Nearly 1 Celularity Inc CELU Surges 8 to 099 as Stock Tests Key Resistance Eaton Vance TaxManaged BuyWrite Income Fund ETB Holds Steady With Modest Gain as Income Strategy Remains in Focus GE HealthCare Technologies GEHC Holds Steady Near Resistance Zone Microsofts Trusted Technology Group Chief Advocates Responsible AI Development NXST Q1 2026 Earnings Strong EPS Beat Amidst Modest Stock Decline as Nexstar Outperforms Estimates Penguin Solutions Inc PENG Rallies 327 as Buyers Test Critical Resistance Near 577 Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations AMPL Q1 2026 Earnings EPS Misses Estimates as Shares Rise Despite Challenging Quarter Sabine Royalty Trust SBR Q3 2009 Earnings Misses Estimates Amid Weak Commodity Prices Stock Holds Steady AFB Q3 2024 Earnings Net Investment Income per Share Reported at 011 No Analyst Estimate Available LITE Q1 2026 Earnings EPS Beats Estimates Revenue Impact Unclear Stock Down 182 ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy RMCO Q4 2025 Earnings Significant EPS Miss as Company Reports Loss